Company · CIK 0001703287
Nabriva Therapeutics Legacy plc
Exchange
—
Entity type
other
Fiscal year end
Dec 31
Headquarters
Ireland
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001104659-17-046316 · 21.9 KBSEC(opens sec.gov)
- 4Insider trades0001179110-17-010365 · 8.9 KBSEC(opens sec.gov)
- 3Nabriva Therapeutics Plc0001104659-17-044504 · 12.9 KBSEC(opens sec.gov)
- 4Insider trades0001179110-17-010236 · 7.4 KBSEC(opens sec.gov)
- 4Insider trades0001104659-17-043682 · 5.5 KBSEC(opens sec.gov)
- 3/ANabriva Therapeutics Plc0001104659-17-042159 · 13.8 KBSEC(opens sec.gov)
- 4Insider trades0001104659-17-041909 · 10.1 KBSEC(opens sec.gov)
- 4Insider trades0001104659-17-041907 · 8.4 KBSEC(opens sec.gov)
- 4Insider trades0001104659-17-041906 · 8.3 KBSEC(opens sec.gov)
- 4Insider trades0001104659-17-041905 · 10.9 KBSEC(opens sec.gov)
Insiders
- Bourdow Carrie L.Director
- Broom Colin MDDirector, Chief Executive Officer
- BURGESS DANIEL DDirector
- CORRIGAN MARKDirector
- Crotty RobertGeneral Counsel & Corp Secreta
- Gelone Steven P.Chief Development Officer
- HBM Healthcare Investments (Cayman) Ltd.10% Owner
- Khuong Chau QuangDirector, 10% Owner
- Lavino Francesco MariaChief Commercial Officer
- Rowland Charles A JrDirector
Tickers
No tickers on record.
Addresses
business
56 FITZWILLIAM SQUARE
DUBLIN, L2, 2
mailing
1000 CONTINENTAL DRIVE SUITE 600
KING OF PRUSSIA, PA, 19406
Former names
- Nabriva Therapeutics Plc2017-07-18
Same industry